Red Eye, Global Challenge
Narrative review calls for clearer guidance on noninfectious conjunctival hyperemia
Clinical Scorecard: Red Eye, Global Challenge
At a Glance
Category Detail
Condition Noninfectious conjunctival hyperemia Key Mechanisms Lifestyle and environmental factors including digital eye strain, contact lens wear, cosmetics, smoking, and pollution. Target Population Individuals experiencing chronic or recurrent redness, particularly those with dry eye disease and ocular allergy. Care Setting Ophthalmology clinics and general healthcare settings.
Key Highlights
Conjunctival hyperemia is a common global ophthalmic presentation. Dry eye disease and ocular allergy are leading causes of redness. Low-dose brimonidine 0.025% shows promise for redness reduction without tachyphylaxis. There is a lack of dedicated management guidelines for noninfectious conjunctival hyperemia. Patients increasingly seek redness relief for cosmetic reasons. Guideline-Based Recommendations
Diagnosis
Clearer diagnostic pathways are needed to differentiate benign redness from sight-threatening emergencies. Management
Consensus recommendations for management of noninfectious conjunctival hyperemia are warranted. Monitoring & Follow-up
Long-term real-world data on treatment efficacy and safety is necessary. Risks
Caution against surgical 'eye-whitening' procedures due to potential serious complications. Patient & Prescribing Data
Patients experiencing redness due to noninfectious causes, particularly those with DED and ocular allergy.
Many patients self-treat with over-the-counter drops, but management is often suboptimal.
Clinical Best Practices
Educate patients on the risks of steroid self-medication. Encourage the use of evidence-based pharmacological options like low-dose brimonidine. Promote better screening tools for accurate diagnosis. Related Resources & Content
